Oncolytics Biotech buy Royal Bank of Canada
Start price
10.03.25
/
50%
€1.61
Target price
10.03.26
€4.60
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 10.03.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Oncolytics Biotech | - | - |
| iShares Core DAX® | 0.760% | -0.301% |
| iShares Nasdaq 100 | 0.732% | -1.001% |
| iShares Nikkei 225® | 1.025% | -3.621% |
| iShares S&P 500 | -0.036% | -0.194% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Oncolytics Biotech diskutieren
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its price target lowered by analysts at Royal Bank of Canada from $6.00 to $5.00. They now have an "outperform" rating on the stock.
Ratings data for ONCY provided by MarketBeat